Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Fabrizio Pane

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (12)

Elisabetta Abruzzese

UNIVERSITY TOR VERGATA

ITALY

View details

Francesca Romana Mauro

ITALY

View details

Antonio Cuneo

Full Professor of Hematology

University of Ferrara

ITALY

View details

Stefano Molica

UNITED KINGDOM

View details

Novella Pugliese

Medical assistant

Università degli Studi di Napoli Federico II

ITALY

View details

PAOLO SPORTOLETTI

Università degli Studi di Napoli Federico II

ITALY

View details

Marco Picardi

Ricercatore Confermato

Federico II University Hospital

ITALY

View details

Ivan Gentile

University of Naples Federico II

ITALY

View details

Pio Zeppa

ITALY

View details

Francesco Grimaldi

Ricercatore Universitario, Dirigente medico

Federico II University Hospital

ITALY

View details

Antonio Vassallo

Associate Professor

Università degli Studi di Napoli Federico II

ITALY

View details

Livio Trentin

Docenti di ruolo di IIa fascia

University of Padova

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabrizio Pane

Research Interests

Explore related searches

Articles (11)

Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study

The progression at 24 months (POD24) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification

Treatment‐Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De‐Escalation: 96‐Week Update of the DANTE Study

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts

Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center

Routine Imaging Surveillance After Frontline ABVD Improves Outcome in High-Risk Hodgkin Lymphoma

Isatuximab, Carfilzomib, and Dexamethasone Combined With Late Autologous Stem Cell Transplantation: A Synergistic Strategy for First Relapse Multiple Myeloma

Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study

Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study

Collaborators (12)

Elisabetta Abruzzese

Francesca Romana Mauro

Antonio Cuneo

Stefano Molica

Novella Pugliese

PAOLO SPORTOLETTI

Marco Picardi

Ivan Gentile

Pio Zeppa

Francesco Grimaldi

Antonio Vassallo

Livio Trentin

Make your next move.